These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13237310)

  • 1. Effect of certain 2,4-diaminopyrimidine antagonists of folic acid on pregnancy and rat fetus.
    THIERSCH JB
    Proc Soc Exp Biol Med; 1954 Dec; 87(3):571-7. PubMed ID: 13237310
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of rat folic acid reductase activity activity by trimethoprim during the later stages of gestation.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(2):227-30. PubMed ID: 4268642
    [No Abstract]   [Full Text] [Related]  

  • 3. Rat folic acid reductase activity during the perinatal period, in newborns, and after trimethoprim administration.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 274(3):229-37. PubMed ID: 4262779
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim and sulfamethoxazole in pregnancy.
    Gonzalez Ochoa A
    JAMA; 1971 Aug; 217(9):1244. PubMed ID: 5109468
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular pharmacokinetics of lipophilic diaminopyrimidine antifolates.
    Greco WR; Hakala MT
    J Pharmacol Exp Ther; 1980 Jan; 212(1):39-46. PubMed ID: 7351624
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiopulmonary effects of antimalarial drugs. 3. Diaminopyrimidines: trimethoprim (WR 5949) and 5-piperonyl-2,4-diaminopyrimidine (WR 40,070).
    Matsuo S; Ruiz R; Smith J; Aviado DM
    Toxicol Appl Pharmacol; 1970 Jul; 17(1):130-50. PubMed ID: 5456632
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical pharmacology of lipophilic diaminopyrimidine antifolates in mouse and human cells in vitro.
    Greco WR; Hakala MT
    Mol Pharmacol; 1980 Nov; 18(3):521-8. PubMed ID: 6970329
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.
    Hampshire J; Hebborn P; Triggle AM; Triggle DJ; Vickers S
    J Med Chem; 1965 Nov; 8(6):745-9. PubMed ID: 5885064
    [No Abstract]   [Full Text] [Related]  

  • 9. Species differences among dihydrofolate reductases as a basis for chemotherapy.
    Hitchings GH
    Postgrad Med J; 1969 Nov; 45():Suppl:7-10. PubMed ID: 5361314
    [No Abstract]   [Full Text] [Related]  

  • 10. ETIOLOGY OF ANTENATAL HYDROCEPHALUS INDUCED BY FOLIC ACID DEFICIENCY IN THE ALBINO RAT.
    STEMPAK JG
    Anat Rec; 1965 Mar; 151():287-95. PubMed ID: 14324085
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimethoprim, a sulphonamide potentiator.
    Bushby SR; Hitchings GH
    Br J Pharmacol Chemother; 1968 May; 33(1):72-90. PubMed ID: 5301731
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppressive powers of the antibacterial agent trimethoprim.
    Ghilchik MW; Morris AS; Reeves DS
    Nature; 1970 Jul; 227(5256):393-4. PubMed ID: 4913712
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of new antimalarial drugs sulfonamides and trimethoprim.
    Aviado DM; Singh G; Berkley R
    Chemotherapy; 1969; 14(1):37-53. PubMed ID: 5814488
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect ot trimethoprim on folate metabolism in human bone marrow.
    Koutts J; Van der Weyden MB; Cooper M
    Aust N Z J Med; 1973 Jun; 3(3):245-50. PubMed ID: 4517220
    [No Abstract]   [Full Text] [Related]  

  • 15. The in vivo effect of folinic acid (citrovorum factor) on the potentiation of the antibacterial activity of sulfisoxazole by trimethoprim.
    Grunberg E; Prince HN; De Lorenzo WF
    J Clin Pharmacol J New Drugs; 1970; 10(4):231-4. PubMed ID: 4913356
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors.
    McCormick GJ; Canfield CJ; Willet GP
    Exp Parasitol; 1971 Aug; 30(1):88-93. PubMed ID: 5316583
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of the diaminopyrimidines.
    Burchall JJ
    J Antimicrob Chemother; 1979 Nov; 5(B):3-14. PubMed ID: 395152
    [No Abstract]   [Full Text] [Related]  

  • 18. Septrin and bactrim. A combination of trimethoprim and sulphamethoxazole.
    Drug Ther Bull; 1969 Feb; 7(4):13-5. PubMed ID: 5770286
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of sulfamethoxazole plus trimethoprim in man and their distribution in the rat.
    Schwartz DE; Rieder J
    Chemotherapy; 1970; 15(6):337-55. PubMed ID: 5514974
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the teratogenic folic acid antagonist, 9-methyl pteroylglutamic acid, on hydroxyproline levels in fetal rat limbs.
    Schmidt RR; Chepenik KP; Paynton BV
    J Embryol Exp Morphol; 1977 Oct; 41():289-94. PubMed ID: 591876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.